Neurexis Therapeutics

0 followers


Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.

Industries

Headquarters

Stage

Employees

Links

Org chart

Michael Artinger
CEO & Board Member

Michael Artinger

Collapse
Ulli Bayer
CSO & Board Member
Robyn Goforth
VP, Research & Development